Close

BofA/Merrill Lynch Starts Aegerion Pharmaceuticals (AEGR) at Buy

March 5, 2013 7:13 AM EST Send to a Friend
BofA/Merrill Lynch initiates coverage on Aegerion Pharmaceuticals (NASDAQ: AEGR) with a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login